WHO Members Take Steps Against Global Rise In Sales Of Human Body Parts 09/06/2017 Elise De Geyter The World Health Assembly last week adopted ten guiding ethical principles for the donation and management of medical products of human origin – that is, the rising market for body parts. Continue reading -> Industry, NGOs On Staff At WHO? Beware Of Revolving Doors, Some Say 06/06/2017 Catherine Saez The agreement found last year after months of intense discussion to avert the possibility of undue influence by outside actors at the World Health Organization is yet to be fully implemented. The World Health Assembly last week looked at progress and the process by which the WHO can temporarily welcome on its staff individuals from the private sector, civil society, philanthropic foundations, and academic institutions. Some countries questioned principles in this process but were told by the WHO that their comments would merely be recorded. Continue reading -> Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> New Draft Decision Seeks To Deepen Analysis On WHO Pandemic Flu Framework 24/05/2017 Catherine Saez A new draft decision submitted this week at the World Health Assembly (WHA) by a group of countries would set out further actions to analyse the Pandemic Influenza Preparedness (PIP) Framework. Continue reading -> Antimicrobial Resistance Needs New R&D Models, NGOs Say 24/05/2017 Catherine Saez A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for new antibiotics, and the imperative of affordability and accessibility of new products. The speakers mentioned alternative models, such as delinking the cost of research from the price of the medicines, underlined the high prices of vaccines, and the importance of systems of infection prevention and control. Continue reading -> NCD Alliance Event: Time For Action Against Noncommunicable Diseases 24/05/2017 Elise De Geyter It might be said it is a “golden moment” for fighting noncommunicable diseases. There have never been as many side events on noncommunicable diseases during the World Health Assembly as this year, according to speakers at an event of the NCD Alliance this week. Continue reading -> IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> Humanity Moves Into ‘Unknown” as Warming Earth Transgresses Planetary Boundaries 17/07/2025 Maayan Hoffman After 2024 became the warmest year on record, with temperatures rising 1.5 °C above pre-industrial levels for the first time ever, humanity is “moving into the unknown,” said Andy Haines, professor of environmental change and public health at the London School of Hygiene & Tropical Medicine. “We are now above the Paris Agreement’s preferred target […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Industry, NGOs On Staff At WHO? Beware Of Revolving Doors, Some Say 06/06/2017 Catherine Saez The agreement found last year after months of intense discussion to avert the possibility of undue influence by outside actors at the World Health Organization is yet to be fully implemented. The World Health Assembly last week looked at progress and the process by which the WHO can temporarily welcome on its staff individuals from the private sector, civil society, philanthropic foundations, and academic institutions. Some countries questioned principles in this process but were told by the WHO that their comments would merely be recorded. Continue reading -> Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> New Draft Decision Seeks To Deepen Analysis On WHO Pandemic Flu Framework 24/05/2017 Catherine Saez A new draft decision submitted this week at the World Health Assembly (WHA) by a group of countries would set out further actions to analyse the Pandemic Influenza Preparedness (PIP) Framework. Continue reading -> Antimicrobial Resistance Needs New R&D Models, NGOs Say 24/05/2017 Catherine Saez A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for new antibiotics, and the imperative of affordability and accessibility of new products. The speakers mentioned alternative models, such as delinking the cost of research from the price of the medicines, underlined the high prices of vaccines, and the importance of systems of infection prevention and control. Continue reading -> NCD Alliance Event: Time For Action Against Noncommunicable Diseases 24/05/2017 Elise De Geyter It might be said it is a “golden moment” for fighting noncommunicable diseases. There have never been as many side events on noncommunicable diseases during the World Health Assembly as this year, according to speakers at an event of the NCD Alliance this week. Continue reading -> IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> Humanity Moves Into ‘Unknown” as Warming Earth Transgresses Planetary Boundaries 17/07/2025 Maayan Hoffman After 2024 became the warmest year on record, with temperatures rising 1.5 °C above pre-industrial levels for the first time ever, humanity is “moving into the unknown,” said Andy Haines, professor of environmental change and public health at the London School of Hygiene & Tropical Medicine. “We are now above the Paris Agreement’s preferred target […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Decision On Pandemic Flu Framework At WHA: Look Closer At Changes 26/05/2017 Catherine Saez A committee at the World Health Assembly yesterday decided to seek a closer look at consequences of potential changes to the WHO framework on pandemic influenza. The decision, still to be confirmed by the World Health Assembly, requires in-depth analysis of how to handle pandemic flu viruses under the framework, whether the framework should cover seasonal influenza, and whether the framework should become a specialised international instrument on access and benefit-sharing. Continue reading -> Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> New Draft Decision Seeks To Deepen Analysis On WHO Pandemic Flu Framework 24/05/2017 Catherine Saez A new draft decision submitted this week at the World Health Assembly (WHA) by a group of countries would set out further actions to analyse the Pandemic Influenza Preparedness (PIP) Framework. Continue reading -> Antimicrobial Resistance Needs New R&D Models, NGOs Say 24/05/2017 Catherine Saez A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for new antibiotics, and the imperative of affordability and accessibility of new products. The speakers mentioned alternative models, such as delinking the cost of research from the price of the medicines, underlined the high prices of vaccines, and the importance of systems of infection prevention and control. Continue reading -> NCD Alliance Event: Time For Action Against Noncommunicable Diseases 24/05/2017 Elise De Geyter It might be said it is a “golden moment” for fighting noncommunicable diseases. There have never been as many side events on noncommunicable diseases during the World Health Assembly as this year, according to speakers at an event of the NCD Alliance this week. Continue reading -> IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> Humanity Moves Into ‘Unknown” as Warming Earth Transgresses Planetary Boundaries 17/07/2025 Maayan Hoffman After 2024 became the warmest year on record, with temperatures rising 1.5 °C above pre-industrial levels for the first time ever, humanity is “moving into the unknown,” said Andy Haines, professor of environmental change and public health at the London School of Hygiene & Tropical Medicine. “We are now above the Paris Agreement’s preferred target […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antimicrobial Resistance: PPPs The Way Forward, Speakers Say 25/05/2017 Catherine Saez With global funding for research and development decreasing, and the growing threat of antimicrobial resistance, ways to incentivise research are seen as key to solving the problem. Speakers at a side event to the World Health Assembly this week presented models of public and private partnerships to address the issue. Continue reading -> New Draft Decision Seeks To Deepen Analysis On WHO Pandemic Flu Framework 24/05/2017 Catherine Saez A new draft decision submitted this week at the World Health Assembly (WHA) by a group of countries would set out further actions to analyse the Pandemic Influenza Preparedness (PIP) Framework. Continue reading -> Antimicrobial Resistance Needs New R&D Models, NGOs Say 24/05/2017 Catherine Saez A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for new antibiotics, and the imperative of affordability and accessibility of new products. The speakers mentioned alternative models, such as delinking the cost of research from the price of the medicines, underlined the high prices of vaccines, and the importance of systems of infection prevention and control. Continue reading -> NCD Alliance Event: Time For Action Against Noncommunicable Diseases 24/05/2017 Elise De Geyter It might be said it is a “golden moment” for fighting noncommunicable diseases. There have never been as many side events on noncommunicable diseases during the World Health Assembly as this year, according to speakers at an event of the NCD Alliance this week. Continue reading -> IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> Humanity Moves Into ‘Unknown” as Warming Earth Transgresses Planetary Boundaries 17/07/2025 Maayan Hoffman After 2024 became the warmest year on record, with temperatures rising 1.5 °C above pre-industrial levels for the first time ever, humanity is “moving into the unknown,” said Andy Haines, professor of environmental change and public health at the London School of Hygiene & Tropical Medicine. “We are now above the Paris Agreement’s preferred target […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Draft Decision Seeks To Deepen Analysis On WHO Pandemic Flu Framework 24/05/2017 Catherine Saez A new draft decision submitted this week at the World Health Assembly (WHA) by a group of countries would set out further actions to analyse the Pandemic Influenza Preparedness (PIP) Framework. Continue reading -> Antimicrobial Resistance Needs New R&D Models, NGOs Say 24/05/2017 Catherine Saez A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for new antibiotics, and the imperative of affordability and accessibility of new products. The speakers mentioned alternative models, such as delinking the cost of research from the price of the medicines, underlined the high prices of vaccines, and the importance of systems of infection prevention and control. Continue reading -> NCD Alliance Event: Time For Action Against Noncommunicable Diseases 24/05/2017 Elise De Geyter It might be said it is a “golden moment” for fighting noncommunicable diseases. There have never been as many side events on noncommunicable diseases during the World Health Assembly as this year, according to speakers at an event of the NCD Alliance this week. Continue reading -> IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> Humanity Moves Into ‘Unknown” as Warming Earth Transgresses Planetary Boundaries 17/07/2025 Maayan Hoffman After 2024 became the warmest year on record, with temperatures rising 1.5 °C above pre-industrial levels for the first time ever, humanity is “moving into the unknown,” said Andy Haines, professor of environmental change and public health at the London School of Hygiene & Tropical Medicine. “We are now above the Paris Agreement’s preferred target […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antimicrobial Resistance Needs New R&D Models, NGOs Say 24/05/2017 Catherine Saez A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for new antibiotics, and the imperative of affordability and accessibility of new products. The speakers mentioned alternative models, such as delinking the cost of research from the price of the medicines, underlined the high prices of vaccines, and the importance of systems of infection prevention and control. Continue reading -> NCD Alliance Event: Time For Action Against Noncommunicable Diseases 24/05/2017 Elise De Geyter It might be said it is a “golden moment” for fighting noncommunicable diseases. There have never been as many side events on noncommunicable diseases during the World Health Assembly as this year, according to speakers at an event of the NCD Alliance this week. Continue reading -> IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> Humanity Moves Into ‘Unknown” as Warming Earth Transgresses Planetary Boundaries 17/07/2025 Maayan Hoffman After 2024 became the warmest year on record, with temperatures rising 1.5 °C above pre-industrial levels for the first time ever, humanity is “moving into the unknown,” said Andy Haines, professor of environmental change and public health at the London School of Hygiene & Tropical Medicine. “We are now above the Paris Agreement’s preferred target […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
NCD Alliance Event: Time For Action Against Noncommunicable Diseases 24/05/2017 Elise De Geyter It might be said it is a “golden moment” for fighting noncommunicable diseases. There have never been as many side events on noncommunicable diseases during the World Health Assembly as this year, according to speakers at an event of the NCD Alliance this week. Continue reading -> IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> Humanity Moves Into ‘Unknown” as Warming Earth Transgresses Planetary Boundaries 17/07/2025 Maayan Hoffman After 2024 became the warmest year on record, with temperatures rising 1.5 °C above pre-industrial levels for the first time ever, humanity is “moving into the unknown,” said Andy Haines, professor of environmental change and public health at the London School of Hygiene & Tropical Medicine. “We are now above the Paris Agreement’s preferred target […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> Humanity Moves Into ‘Unknown” as Warming Earth Transgresses Planetary Boundaries 17/07/2025 Maayan Hoffman After 2024 became the warmest year on record, with temperatures rising 1.5 °C above pre-industrial levels for the first time ever, humanity is “moving into the unknown,” said Andy Haines, professor of environmental change and public health at the London School of Hygiene & Tropical Medicine. “We are now above the Paris Agreement’s preferred target […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> Humanity Moves Into ‘Unknown” as Warming Earth Transgresses Planetary Boundaries 17/07/2025 Maayan Hoffman After 2024 became the warmest year on record, with temperatures rising 1.5 °C above pre-industrial levels for the first time ever, humanity is “moving into the unknown,” said Andy Haines, professor of environmental change and public health at the London School of Hygiene & Tropical Medicine. “We are now above the Paris Agreement’s preferred target […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Humanity Moves Into ‘Unknown” as Warming Earth Transgresses Planetary Boundaries 17/07/2025 Maayan Hoffman After 2024 became the warmest year on record, with temperatures rising 1.5 °C above pre-industrial levels for the first time ever, humanity is “moving into the unknown,” said Andy Haines, professor of environmental change and public health at the London School of Hygiene & Tropical Medicine. “We are now above the Paris Agreement’s preferred target […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy